Logo image of IBO.CA

UNIVERSAL IBOGAINE INC (IBO.CA) Stock Price, Forecast & Analysis

Canada - TSX Venture Exchange - TSX-V:IBO - CA91360F1099 - Common Stock

0.01 CAD
0 (0%)
Last: 12/24/2025, 7:00:00 PM

IBO.CA Key Statistics, Chart & Performance

Key Statistics
Market Cap3.13M
Revenue(TTM)2.06M
Net Income(TTM)-1.48M
Shares312.86M
Float270.81M
52 Week High0.05
52 Week Low0.01
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-0.01
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO2017-06-21
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A


IBO.CA short term performance overview.The bars show the price performance of IBO.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30 -40 -50

IBO.CA long term performance overview.The bars show the price performance of IBO.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40 -50

The current stock price of IBO.CA is 0.01 CAD. In the past year, price decreased by -33.33%.

UNIVERSAL IBOGAINE INC / IBO Daily stock chart

About IBO.CA

Company Profile

IBO logo image Universal Ibogaine, Inc. engages in developing ibogaine based drug franchise to treat addiction and related mental health issues. The company is headquartered in Calgary, Alberta. The company went IPO on 2017-06-21. The firm is transforming addiction treatment using medicalized ibogaine through a planned Canadian clinical trial focused on opioid use disorders. The firm is engaged in developing a holistic addiction treatment protocol at its Kelburn Recovery Center (located near Winnipeg, Manitoba), which, paired with the planned ibogaine detox protocol, is intended to treat addiction and improve the lives of individuals and families affected by addiction. Ibogaine is a naturally occurring molecule derived from the root bark of the iboga tree and other plants. The company is a potent and serious medical psychedelic which has addiction interrupting properties. Ibogaine targets multiple receptors across multiple sites in the brain and metabolizes into noribogaine, a serotonin re-uptake inhibitor that remains in the body for about 1-4 months, associated with elimination of addictive cravings.

Company Info

UNIVERSAL IBOGAINE INC

(c/o Suite 600 - 815 8th Avenue SW

Calgary ALBERTA CA

Employees: 0

IBO Company Website

IBO Investor Relations

Phone: 14038701841.0

UNIVERSAL IBOGAINE INC / IBO.CA FAQ

Can you describe the business of UNIVERSAL IBOGAINE INC?

Universal Ibogaine, Inc. engages in developing ibogaine based drug franchise to treat addiction and related mental health issues. The company is headquartered in Calgary, Alberta. The company went IPO on 2017-06-21. The firm is transforming addiction treatment using medicalized ibogaine through a planned Canadian clinical trial focused on opioid use disorders. The firm is engaged in developing a holistic addiction treatment protocol at its Kelburn Recovery Center (located near Winnipeg, Manitoba), which, paired with the planned ibogaine detox protocol, is intended to treat addiction and improve the lives of individuals and families affected by addiction. Ibogaine is a naturally occurring molecule derived from the root bark of the iboga tree and other plants. The company is a potent and serious medical psychedelic which has addiction interrupting properties. Ibogaine targets multiple receptors across multiple sites in the brain and metabolizes into noribogaine, a serotonin re-uptake inhibitor that remains in the body for about 1-4 months, associated with elimination of addictive cravings.


What is the stock price of UNIVERSAL IBOGAINE INC today?

The current stock price of IBO.CA is 0.01 CAD.


Does IBO stock pay dividends?

IBO.CA does not pay a dividend.


How is the ChartMill rating for UNIVERSAL IBOGAINE INC?

IBO.CA has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 0 out of 10.


Which stock exchange lists IBO stock?

IBO.CA stock is listed on the TSX Venture Exchange exchange.


Would investing in UNIVERSAL IBOGAINE INC be a good decision?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on IBO.CA.


IBO.CA Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to IBO.CA. When comparing the yearly performance of all stocks, IBO.CA is a bad performer in the overall market: 88.34% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

IBO.CA Financial Highlights

Over the last trailing twelve months IBO.CA reported a non-GAAP Earnings per Share(EPS) of -0.01. The EPS increased by 22.39% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -36.85%
ROE -542.4%
Debt/Equity 6.33
Chartmill High Growth Momentum
EPS Q2Q%93.33%
Sales Q2Q%30.59%
EPS 1Y (TTM)22.39%
Revenue 1Y (TTM)-11.69%

IBO.CA Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

IBO.CA Ownership

Ownership
Inst OwnersN/A
Ins Owners13.44%
Short Float %N/A
Short RatioN/A